Plant polyphenols as natural drugs for the management of Down syndrome and related disorders

Neuroscience and Biobehavioral Reviews

Volumn 71, Issue , 2016, Pages 865-877

  Vacca, Rosa Anna ^a   Valenti, Daniela ^a   Caccamese, Salvatore ^b   Daglia, Maria ^c   Braidy, Nady ^d   Nabavi, Seyed Mohammad ^e,f  

^a CNR   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Down syndrome; EGCG; Hydroxytyrosol; Intellectual disability; Mitochondria; Neurodevelopment diseases; Neuroprotection; Oxidative stress; Polyphenols; Resveratrol

Indexed keywords

CURCUMIN; EPIGALLOCATECHIN GALLATE; HYDROXYTYROSOL; POLYPHENOL; QUERCETIN; RESVERATROL; BIOLOGICAL PRODUCT; CATECHIN;

AGING; COGNITIVE DEFECT; DIETARY SUPPLEMENT; DOWN SYNDROME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TARGETING; EX VIVO STUDY; EXPERIMENTAL ANIMAL; HUMAN; IN VITRO STUDY; INTELLECTUAL IMPAIRMENT; MENTAL PERFORMANCE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; MITOCHONDRION;

BIOLOGICAL PRODUCTS; CATECHIN; DOWN SYNDROME; HUMANS; MITOCHONDRIA; POLYPHENOLS;

EID: 84995757440     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.10.023     Document Type: Review

References (152)

1. Abib, R.T., Peres, K.C., Barbosa, A.M., Peres, T.V., Bernardes, A., Zimmermann, L.M., Quincozes-Santos, A., Fiedler, H.D., Leal, R.B., Farina, M., Epigallocatechin-3-gallate protects rat brain mitochondria against cadmium-induced damage. Food Chem. Toxicol. 49 (2011), 2618–2623.
2. Ahmed, T., Javed, S., Javed, S., Tariq, A., Šamec, D., Tejada, S., Nabavi, S.F., Braidy, N., Nabavi, S.M., Resveratrol and Alzheimer's disease: mechanistic insights. Mol. Neurobiol., 2016, 10.1007/s12035-016-9839-9.
3. Aires, V., Delmas, D., Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies. Curr. Pharm. Biotechnol. 16 (2015), 219–244.
4. Amorini, A.M., Giorlandino, C., Longo, S., D'Urso, S., Mesoraca, A., Santoro, M.L., Picardi, M., Gullotta, S., Cignini, P., Lazzarino, D., Metabolic profile of amniotic fluid as a biochemical tool to screen for inborn errors of metabolism and fetal anomalies. Mol. Cell. Biochem. 359 (2012), 205–216.
5. Arun, S., Liu, L., Donmez, G., Mitochondrial biology and neurological diseases. Curr. Neuropharmacol. 14 (2016), 143–154.
6. Atanasov, A.G., Waltenberger, B., Pferschy-Wenzig, E.M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E.H., Rollinger, J.M., Schuster, D., Breuss, J.M., Bochkov, V., Mihovilovic, M.D., Kopp, B., Bauer, R., Dirsch, V.M., Stuppner, H., Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 33 (2015), 1582–1614.
7. Bastianetto, S., Zheng, W.H., Quirion, R., Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br. J. Pharmacol. 131 (2000), 711–720.
8. Bastianetto, S., Ménard, C., Quirion, R., Neuroprotective action of resveratrol. Biochim. Biophys. Acta (BBA) 1852 (2015), 1195–1201.
9. Baum, L., Lam, C.W.K., Cheung, S.K.K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28 (2008), 110–113.
10. Bhandari, R., Kuhad, A., Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sci. 141 (2015), 156–169.
11. Castellano-González, G., Pichaud, N., Ballard, J.W.O., Bessede, A., Marcal, H., Guillemin, G.J., Epigallocatechin-3-gallate induces oxidative phosphorylation by activating cytochrome c oxidase in human cultured neurons and astrocytes. Oncotarget 7 (2016), 7426–7440.
12. Castrejón-Tellez, V., Rodríguez-Pérez, J.M., Pérez-Torres, I., Pérez-Hernández, N., Cruz-Lagunas, A., Guarner-Lans, V., Vargas-Alarcón, G., Rubio-Ruiz, M.E., The effect of resveratrol and quercetin treatment on PPAR mediated uncoupling protein (UCP-) 1, 2 and 3 expression in visceral white adipose tissue from metabolic syndrome rats. Int. J. Mol. Sci., 17, 2016, 1069.
13. Chachay, V.S., Kirkpatrick, C.M., Hickman, I.J., Ferguson, M., Prins, J.B., Martin, J.H., Resveratrol–pills to replace a healthy diet?. Br. J. Clin. Pharmacol. 72 (2011), 27–38.
14. Chang, C.W., Wong, C.Y., Wu, Y.T., Hsu, M.C., Development of a solid dispersion system for improving the oral bioavailability of resveratrol in rats. Eur. J. Drug Metab. Pharmacokinet., 2016, 1–11.
15. Chen, D., Pamu, S., Cui, Q., Chan, T.H., Dou, Q.P., Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg. Med. Chem. 20:9 (2012), 3031–3037.
16. Cho, A.R., Chun, Y.G., Kim, B.K., Park, D.J., Preparation of chitosan–TPP microspheres as resveratrol carriers. J. Food Sci. 79 (2014), E568–E576.
17. Chowdhury, A., Sarkar, J., Chakraborti, T., Pramanik, P.K., Chakraborti, S., Protective role of epigallocatechin-3-gallate in health and disease: a perspective. Biomed. Pharmacother. 78 (2016), 50–59.
18. Coppedè, F., Risk factors for down syndrome. Arch. Toxicol., 2016 (Epub ahead of print).
19. Costa, S., Utan, A., Cervellati, R., Speroni, E., Guerra, M., Catechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1). Food Chem. Toxicol. 45 (2007), 1910–1917.
20. Covas, M.I., De La Torre, K., Farré-Albaladejo, M., Kaikkonen, J., Fitó, M., López-Sabater, C., Pujadas-Bastardes, M.A., Joglar, J., Weinbrenner, T., Lamuela-Raventós, R.M., Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic. Biol. Med. 40 (2006), 608–616.
21. Curti, V., Capelli, E., Boschi, F., Nabavi, S.F., Bongiorno, A.I., Habtemariam, S., Nabavi, S.M., Daglia, M., Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. Mol. Nutr. Food Res. 58 (2014), 1776–1784.
22. D'Archivio, M., Filesi, C., Varì, R., Scazzocchio, B., Masella, R., Bioavailability of the polyphenols: status and controversies. Int. J. Mol. Sci. 11 (2010), 1321–1342.
23. D'Andrea, G., Quercetin: a flavonol with multifaceted therapeutic applications?. Fitoterapia 106 (2015), 256–271.
24. Daglia, M., Di Lorenzo, A., Nabavi, S.F., Talas, Z.S., Nabavi, S.M., Polyphenols. well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!. Curr. Pharm. Biotechnol. 15 (2014), 362–372.
25. Das, S., Lin, H.S., Ho, P.C., Ng, K.Y., The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm. Res. 25 (2008), 2593–2600.
26. Dasgupta, B., Milbrandt, J., Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. 104 (2007), 7217–7222.
27. De Filippis, B., Valenti, D., de Bari, L., De Rasmo, D., Musto, M., Fabbri, A., Ricceri, L., Fiorentini, C., Laviola, G., Vacca, R.A., Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1. Free Radic. Biol. Med. 83 (2015), 167–177.
28. De la Torre, R., De Sola, S., Pons, M., Duchon, A., de Lagran, M.M., Farré, M., Fitó, M., Benejam, B., Langohr, K., Rodriguez, J., Pujadas, M., Bizot, J.C., Cuenca, A., Janel, N., Catuara, S., Covas, M.I., Blehaut, H., Herault, Y., Delabar, J.M., Dierssen, M., Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in down syndrome mouse models and in humans. Mol. Nutr. Food Res. 58 (2014), 278–288.
29. de Oliveira, M.R., Nabavi, S.M., Braidy, N., Setzer, W.N., Ahmed, T., Nabavi, S.F., Quercetin and the mitochondria: a mechanistic view. Biotechnol. Adv. 34:5 (2016), 532–549.
30. de Oliveira, M.R., Nabavi, S.F., Daglia, M., Rastrelli, L., Nabavi, S.M., Epigallocatechin gallate and mitochondria—a story of life and death. Pharmacol. Res. 104 (2016), 70–85.
31. de Oliveira, M.R., Nabavi, S.F., Manayi, A., Daglia, M., Hajheydari, Z., Nabavi, S.M., Resveratrol and the mitochondria: from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochim. Biophys. Acta (BBA) 1860 (2016), 727–745.
32. de Pace, R.C.C., Liu, X., Sun, M., Nie, S., Zhang, J., Cai, Q., Gao, W., Pan, X., Fan, Z., Wang, S., Anticancer activities of (−)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J. Liposome Res. 23 (2013), 187–196.
33. de la Torre, R., de Sola, S., Hernandez, G., Farré, M., Pujol, J., Rodriguez, J., Espadaler, J.M., Langohr, K., Cuenca-Royo, A., Principe, A., Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with down's syndrome (TESDAD): a double-blind randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 15 (2016), 801–810.
34. Dick, M.B., Doran, E., Phelan, M., Lott, I.T., Cognitive profiles on the severe impairment battery are similar in Alzheimer disease and down syndrome with dementia. Alzheimer Dis. Assoc. Disord. 30:3 (2016), 251–257.
35. Dragicevic, N., Smith, A., Lin, X., Yuan, F., Copes, N., Delic, V., Tan, J., Cao, C., Shytle, R.D., Bradshaw, P.C., Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. J. Alzheimer's Dis. 26 (2011), 507–521.
36. Ebrahimi, A., Schluesener, H., Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res. Rev. 11 (2012), 329–345.
37. Fantini, M., Benvenuto, M., Masuelli, L., Frajese, G.V., Tresoldi, I., Modesti, A., Bei, R., In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int. J. Mol. Sci. 16 (2015), 9236–9282.
38. Frozza, R.L., Bernardi, A., Paese, K., Hoppe, J.B., Silva T. d. Battastini, A.M., Pohlmann, A.R., Guterres, S.S., Salbego, C., Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J. Biomed. Nanotechnol. 6 (2010), 694–703.
39. Gawande, S., Kale, A., Kotwal, S., Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (−) epigallocatechin-3-gallate from green tea extract: a human study. Phytother. Res. 22 (2008), 802–808.
40. Gibellini, L., Bianchini, E., De Biasi, S., Nasi, M., Cossarizza, A., Pinti, M., Natural compounds modulating mitochondrial functions. Evid. Based Complement. Altern. Med., 2015, 2015, 527209.
41. Giunta, B., Hou, H., Zhu, Y., Salemi, J., Ruscin, A., Shytle, R.D., Tan, J., Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice. Neurosci. Lett. 471 (2010), 134–138.
42. Goldberg, D.M., Yan, J., Soleas, G.J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36 (2003), 79–87.
43. Gracia, A., Miranda, J., Fernández-Quintela, A., Eseberri, I., Garcia-Lacarte, M., Milagro, F.I., Martínez, J.A., Aguirre, L., Portillo, M.P., Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue. Food Funct. 7 (2016), 1680–1688.
44. Granados-Principal, S., Quiles, J.L., Ramirez-Tortosa, C.L., Sanchez-Rovira, P., Ramirez-Tortosa, M.C., Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr. Rev. 68 (2010), 191–206.
45. Grieco, J., Pulsifer, M., Seligsohn, K., Skotko, B., Schwartz, A., Down syndrome: cognitive and behavioral functioning across the lifespan. Am. J. Med. Genet. Part C: Semin. Med. Genet. Wiley Online Library, 2015, 135–149.
46. Grimm, A., Friedland, K., Eckert, A., Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease. Biogerontology 17 (2016), 281–296.
47. Grootaert, C., Kamiloglu, S., Capanoglu, E., Van Camp, J., Cell systems to investigate the impact of polyphenols on cardiovascular health. Nutrients 7 (2015), 9229–9255.
48. Gueant, J., Anello, G., Bosco, P., Gueant-Rodriguez, R., Romano, A., Barone, C., Gérard, P., Romano, C., Homocysteine and related genetic polymorphisms in down's syndrome IQ. J. Neurol. Neurosurg. Psychiatry 76 (2005), 706–709.
49. Gupta, S.C., Patchva, S., Aggarwal, B.B., Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 15 (2013), 195–218.
50. Hamlett, E.D., Boger, H.A., Ledreux, A., Kelley, C.M., Mufson, E.J., Falangola, M.F., Guilfoyle, D.N., Nixon, R.A., Patterson, D., Duval, N., Cognitive impairment, neuroimaging, and Alzheimer neuropathology in mouse models of down syndrome. Curr. Alzheimer Res. 13 (2016), 35–52.
51. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.-L., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003), 191–196.
52. Hultén, M.A., Patel, S., Jonasson, J., Iwarsson, E., On the origin of the maternal age effect in trisomy 21 down syndrome: the oocyte mosaicism selection model. Reproduction 139 (2010), 1–9.
53. Hussain, T., Gupta, S., Adhami, V.M., Mukhtar, H., Green tea constituent epigallocatechin‐3‐gallate selectively inhibits COX‐2 without affecting COX‐1 expression in human prostate carcinoma cells. Int. J. Cancer 113 (2005), 660–669.
54. Hussain, Z., Katas, H., Amin, M.C.I.M., Kumolosasi, E., Buang, F., Sahudin, S., Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model. Int. J. Pharm. 444 (2013), 109–119.
55. Hwang, S.L., Shih, P.H., Yen, G.C., Neuroprotective effects of citrus flavonoids. J. Agric. Food Chem. 60 (2012), 877–885.
56. Iacobazzi, V., Infantino, V., Castegna, A., Andria, G., Hyperhomocysteinemia: related genetic diseases and congenital defects: abnormal DNA methylation and newborn screening issues. Mol. Genet. Metab. 113 (2014), 27–33.
57. Ji, H., Zhang, X., Du, Y., Liu, H., Li, S., Li, L., Polydatin modulates inflammation by decreasing NF-κB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates blood-brain barrier permeability for its neuroprotective effect in pMCAO rat brain. Brain Res. Bull. 87 (2012), 50–59.
58. Johnson, J.J., Nihal, M., Siddiqui, I.A., Scarlett, C.O., Bailey, H.H., Mukhtar, H., Ahmad, N., Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 55 (2011), 1169–1176.
59. Kale, A., Gawande, S., Kotwal, S., Netke, S., Roomi, W., Ivanov, V., Niedzwiecki, A., Rath, M., Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract. Phytother. Res. 24 (2010), S48–S55.
60. Karuppagounder, S.S., Pinto, J.T., Xu, H., Chen, H.-L., Beal, M.F., Gibson, G.E., Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 54 (2009), 111–118.
61. Kim, H.S., Montana, V., Jang, H.J., Parpura, V., Kim, J.A., Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role forreducing lipid accumulation. J. Biol. Chem. 288 (2013), 22693–22705.
62. Kołodziejczyk, J., Malinowska, J., Olas, B., Stochmal, A., Oleszek, W., Erler, J., The polyphenol-rich extract from grape seeds suppresses toxicity of homocysteine and its thiolactone on the fibrinolytic system. Thromb. Res. 127 (2011), 489–491.
63. Kubota, S., Kurihara, T., Mochimaru, H., Satofuka, S., Noda, K., Ozawa, Y., Oike, Y., Ishida, S., Tsubota, K., Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and Nuclear factor–κB activation. Invest. Ophthalmol. Vis. Sci. 50 (2009), 3512–3519.
64. Kulkarni, S.S., Cantó, C., The molecular targets of resveratrol. Biochim. Biophys. Acta (BBA) 1852 (2015), 1114–1123.
65. Kumar, A., Prakash, A., Dogra, S., Protective effect of curcumin (Curcuma longa) against D-galactose-induced senescence in mice. J. Asian Nat. Prod. Res. 13 (2011), 42–55.
66. Kurita, S., Kashiwagi, T., Ebisu, T., Shimamura, T., Ukeda, H., Content of resveratrol and glycoside and its contribution to the antioxidative capacity of Polygonum cuspidatum (Itadori) harvested in Kochi. Biosci. Biotechnol. Biochem. 78 (2014), 499–502.
67. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127 (2006), 1109–1122.
68. Lambert, J.D., Hong, J., Kim, D.H., Mishin, V.M., Yang, C.S., Piperine enhances the bioavailability of the tea polyphenol (−)-epigallocatechin-3-gallate in mice. J. Nutr. 134 (2004), 1948–1952.
69. Lambert, J.D., Kim, D.H., Zheng, R., Yang, C.S., Transdermal delivery of (−)‐epigallocatechin‐3‐gallate, a green tea polyphenol, in mice. J. Pharm. Pharmacol. 58 (2006), 599–604.
70. Lambert, J.D., Kwon, S.J., Ju, J., Bose, M., Lee, M.J., Hong, J., Hao, X., Yang, C.S., Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (−)-epigallocatechin-3-gallate. Carcinogenesis 29 (2008), 2019–2024.
71. Latruffe, N., Delmas, D., Lizard, G., Tringali, C., Spatafora, C., Vervandier-Fasseur, D., Meunier, P., Resveratrol against major pathologies: from diet prevention to possible alternative chemotherapies with new structural analogues. Tringali, C., (eds.) Bioactive Compounds from Natural Sources, Natural Products as Lead Compounds in Drug Discovery, 2nd ed., 2012, CRC Press-Taylor&Francis, Boca Raton, 339–378.
72. Latruffe, N., Lançon, A., Frazzi, R., Aires, V., Delmas, D., Michaille, J.J., Djouadi, F., Bastin, J., Cherkaoui-Malki, M., Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation. Ann. N. Y. Acad. Sci. 1348 (2015), 97–106.
73. Lee, J.H., Moon, J.H., Kim, S.W., Jeong, J.K., Nazim, U.M., Lee, Y.J., Seol, J.W., Park, S.Y., EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primaryneuron cells. Oncotarget 6 (2015), 9701–9717.
74. Li, J., Ye, L., Wang, X., Liu, J., Wang, Y., Zhou, Y., Ho, W., (−)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells. J. Neuroinflamm., 9, 2012, 161.
75. Libro, R., Giacoppo, S., Rajan, T.S., Bramanti, P., Mazzon, E., Natural phytochemicals in the treatment and prevention of dementia: an overview. Molecules, 21, 2016, 518.
76. Lin, L.C., Wang, M.N., Tseng, T.Y., Sung, J.S., Tsai, T.H., Pharmacokinetics of (−)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J. Agric. Food Chem. 55 (2007), 1517–1524.
77. Maier-Salamon, A., Böhmdorfer, M., Riha, J., Thalhammer, T., Szekeres, T., Jager, W., Interplay between metabolism and transport of resveratrol. Ann. N. Y. Acad. Sci. 1290 (2013), 90–106.
78. Manna, C., Tagliafierro, L., Scala, I., Granese, B., Andria, G., Zappia, V., The role of iron toxicity in oxidative stress-induced cellular degeneration in down syndrome: protective effects of phenolic antioxidants. Curr. Nutr. Food Sci. 8 (2012), 206–212.
79. Marchese, A., Coppo, E., Sobolev, A.P., Rossi, D., Mannina, L., Daglia, M., Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis). Food Res. Int. 63 (2014), 182–191.
80. Martel, F., Monteiro, R., Calhau, C., Effect of polyphenols on the intestinal and placental transport of some bioactive compounds. Nutr. Res. Rev. 23 (2010), 47–64.
81. Meng, X., Sang, S., Zhu, N., Lu, H., Sheng, S., Lee, M.J., Ho, C.T., Yang, C.S., Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans mice, and rats. Chem. Res. Toxicol. 15 (2002), 1042–1050.
82. Miró-Casas, E., Albaladejo, M.F., Covas, M.I., Rodriguez, J.O., Colomer, E.M., Raventós, R.M.L., De La Torre, R., Capillary gas chromatography–mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake. Anal. Biochem. 294 (2001), 63–72.
83. Molinari, G., Natural products in drug discovery: present status and perspectives. Adv. Exp. Med. Biol. 655 (2009), 13–27.
84. Murakami, I., Chaleckis, R., Pluskal, T., Ito, K., Hori, K., Ebe, M., Yanagida, M., Kondoh, H., Metabolism of skin-absorbed resveratrol into its glucuronized form in mouse skin. PLoS One, 9, 2014, e115359.
85. Murase, T., Haramizu, S., Ota, N., Hase, T., Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology 10 (2009), 423–434.
86. Naasani, I., Oh-hashi, F., Oh-hara, T., Feng, W.Y., Johnston, J., Chan, K., Tsuruo, T., Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 63 (2003), 824–830.
87. Nabavi, S.F., Nabavi, S.M., Latifi, A.M., Mirzaei, M., Habtemariam, S., Moghaddam, A.H., Mitigating role of quercetin against sodium fluoride-induced oxidative stress in the rat brain. Pharmaceut. Biol. 50 (2012), 1380–1383.
88. Nabavi, S.M., Daglia, M., Moghaddam, A.H., Nabavi, S.F., Curti, V., Tea consumption and risk of ischemic stroke: a brief review of the literature. Curr. Pharm. Biotechnol. 15 (2014), 298–303.
89. Nabavi, S.F., Sureda, A., Habtemariam, S., Nabavi, S.M., Ginsenoside Rd and ischemic stroke; a short review of literatures. J. Ginseng Res. 39 (2015), 299–303.
90. Nabavi, S.F., Barber, A.J., Spagnuolo, C., Russo, G.L., Daglia, M., Nabavi, S.M., Sobarzo-Sánchez, E., Nrf2 as molecular target for polyphenols: a novel therapeutic strategy in diabetic retinopathy. Crit. Rev. Clin. Lab. Sci. 53 (2016), 293–312.
91. Neves, A.R., Lucio, M., Martins, S., Lima, J., Reis, S., Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomed. 8 (2013), 177–187.
92. Olmos-Serrano, J.L., Kang, H.J., Tyler, W.A., Silbereis, J.C., Cheng, F., Zhu, Y., Pletikos, M., Jankovic-Rapan, L., Cramer, N.P., Galdzicki, Z., Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron 89 (2016), 1208–1222.
93. Pérez-Hernández, J., Zaldívar-Machorro, V.J., Villanueva-Porras, D., Vega-Ávila, E., Chavarría, A., A potential alternative against neurodegenerative diseases: phytodrugs. Oxid. Med. Cell. Longev., 2016, 2016.
94. Pace, M.C., Passavanti, M.B., Aurilio, C., Sansone, P., Aurilio, R., De Maria, S., Lama, S., Federico, A., Ravagnan, G., Caraglia, M., Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study. In Vivo 29 (2015), 405–408.
95. Panighini, A., Duranti, E., Santini, F., Maffei, M., Pizzorusso, T., Funel, N., Taddei, S., Bernardini, N., Ippolito, C., Virdis, A., Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment. PLoS One, 8, 2013, e64863.
96. Park, J., Song, W.-J., Chung, K.C., Function and regulation of Dyrk1A: towards understanding down syndrome. Cell. Mol. Life Sci. 66 (2009), 3235–3240.
97. Poels, J., Spasić, M.R., Callaerts, P., Norga, K.K., Expanding roles for AmP-activated protein kinase in neuronal survival and autophagy. Bioessays 31 (2009), 944–952.
98. Prohaska, R., Sibon, O.C., Rudnicki, D.D., Danek, A., Hayflick, S.J., Verhaag, E.M., Vonk, J.J., Margolis, R.L., Walker, R.H., Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration. Neurobiol. Dis. 46 (2012), 607–624.
99. Pu, Y., Zhang, H., Wang, P., Zhao, Y., Li, Q., Wei, X., Cui, Y., Sun, J., Shang, Q., Liu, D., Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cell. Physiol. Biochem. 32 (2013), 1167–1177.
100. Quiñones-Lombraña, A., Blanco, J.G., Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting mitochondrial transcription factor a (TFAM). Biochim. Biophys. Acta (BBA) 1852 (2015), 1420–1427.
101. Quideau, S., Why bother with polyphenols. Polyphén. Actual. 24 (2006), 10–14.
102. Rachidi, M., Lopes, C., Mental retardation in down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Neurosci. Res. 59 (2007), 349–369.
103. Ramalingam, P., Ko, Y.T., Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Colloids Surf. B Biointerfaces 139 (2016), 52–61.
104. Rodríguez-Sureda, V., Vilches Á, Sánchez, O., Audí, L., Domínguez, C., Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with Trisomy 21. Oxid. Med. Cell. Longev., 2015, 509241.
105. Rubió, L., Valls, R.M., Macià, A., Pedret, A., Giralt, M., Romero, M.P., de la Torre, R., Covas, M.I., Solà, R., Motilva, M.J., Impact of olive oil phenolic concentration on human plasmatic phenolic metabolites. Food Chem. 135 (2012), 2922–2929.
106. Rugarli, E.I., Langer, T., Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 31 (2012), 1336–1349.
107. Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Russo, G.L., The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83 (2012), 6–15.
108. Sadik, C.D., Sies, H., Schewe, T., Inhibition of 15-lipoxygenases by flavonoids: structure–activity relations and mode of action. Biochem. Pharmacol. 65 (2003), 773–781.
109. Sandhir, R., Mehrotra, A., Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease. Biochim. Biophys. Acta 1832 (2013), 421–430.
110. Sang, S., Cheng, X., Stark, R.E., Rosen, R.T., Yang, C.S., Ho, C.-T., Chemical studies on antioxidant mechanism of tea catechins: analysis of radical reaction products of catechin and epicatechin with 2, 2-diphenyl-1-picrylhydrazyl. Bioorg. Med. Chem. 10 (2002), 2233–2237.
111. Schaffer, S., Podstawa, M., Visioli, F., Bogani, P., Müller, W.E., Eckert, G.P., Hydroxytyrosol-rich olive mill wastewater extract protects brain cells in vitro and ex vivo. J. Agric. Food Chem. 55 (2007), 5043–5049.
112. Serra, A., Rubió, L., Borràs, X., Macià, A., Romero, M.P., Motilva, M.J., Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol. Nutr. Food Res. 56 (2012), 486–496.
113. Sharma, S.B., Gupta, R., Drug development from natural resource: a systematic approach. Mini Rev. Med. Chem. 15 (2015), 52–57.
114. Sharma, S., Zhuang, Y., Ying, Z., Wu, A., Gomez-Pinilla, F., Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma. Neuroscience 161 (2009), 1037–1044.
115. Sharma, D., Wani, W., Sunkaria, A., Kandimalla, R., Sharma, R., Verma, D., Bal, A., Gill, K., Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience 324 (2016), 163–176.
116. Shi, G., Rao, L., Yu, H., Xiang, H., Yang, H., Ji, R., Stabilization and encapsulation of photosensitive resveratrol within yeast cell. Int. J. Pharm. 349 (2008), 83–93.
117. Siddique, M.I., Katas, H., Amin, M.C.I.M., Ng, S.-F., Zulfakar, M.H., Jamil, A., In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis. Int. J. Pharm. 507 (2016), 72–82.
118. Signorile, A., Micelli, L., De Rasmo, D., Santeramo, A., Papa, F., Ficarella, R., Gattoni, G., Scacco, S., Papa, S., Regulation of the biogenesis of OXPHOS complexes in cell transition from replicating to quiescent state: involvement of PKA and effect of hydroxytyrosol. Biochim. Biophys. Acta (BBA) 1843 (2014), 675–684.
119. Singh, G., Pai, R.S., In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol. Artif. cells Nanomed. Biotechnol. 44 (2016), 510–516.
120. Souchet, B., Guedj, F., Penke-Verdier, Z., Daubigney, F., Duchon, A., Herault, Y., Bizot, J.C., Janel, N., Créau, N., Delatour, B., Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models. Front. Behav. Neurosci., 9, 2015, 267.
121. Srividhya, R., Zarkovic, K., Stroser, M., Waeg, G., Zarkovic, N., Kalaiselvi, P., Mitochondrial alterations in aging rat brain: effective role of (−)-epigallo catechin gallate. Int. J. Dev. Neurosci. 27 (2009), 223–231.
122. Stagni, F., Giacomini, A., Guidi, S., Ciani, E., Bartesaghi, R., Timing of therapies for Down syndrome: the sooner, the better. Front. Behav. Neurosci., 9, 2015, 265.
123. Stagni, F., Giacomini, A., Emili, M., Trazzi, S., Guidi, S., Sassi, M., Ciani, E., Rimondini, R., Bartesaghi, R., Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampaldevelopment in the Ts65Dn mouse model of Down syndrome. Neuroscience 333 (2016), 277–301.
124. Taguchi, C., Fukushima, Y., Kishimoto, Y., Suzuki-Sugihara, N., Saita, E., Takahashi, Y., Kondo, K., Estimated dietary polyphenol intake and major food and beverage sources among elderly Japanese. Nutrients 7 (2015), 10269–10281.
125. Teskač, K., Kristl, J., The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390 (2010), 61–69.
126. Trujillo, J., Granados‐Castro, L.F., Zazueta, C., Andérica‐Romero, A.C., Chirino, Y.I., Pedraza‐Chaverrí, J., Mitochondria as a target in the therapeutic properties of curcumin. Arch. Pharm. 347 (2014), 873–884.
127. Tsao, R., Chemistry and biochemistry of dietary polyphenols. Nutrients 2 (2010), 1231–1246.
128. Turner, R.S., Thomas, R.G., Craft, S., Van Dyck, C.H., Mintzer, J., Reynolds, B.A., Brewer, J.B., Rissman, R.A., Raman, R., Aisen, P.S., A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85 (2015), 1383–1391.
129. Vacca, R.A., Valenti, D., Green tea EGCG plus fish oil omega-3 dietary supplements rescue mitochondrial dysfunctions and are safe in a Down's syndrome child. Clin. Nutr. 34 (2015), 783–784.
130. Valenti, D., Manente, G.A., Moro, L., Marra, E., Vacca, R.A., Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. Biochem. J. 435 (2011), 679–688.
131. Valenti, D., De Rasmo, D., Signorile, A., Rossi, L., de Bari, L., Scala, I., Granese, B., Papa, S., Vacca, R.A., Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome. Biochim. Biophys. Acta (BBA) 1832 (2013), 542–552.
132. Valenti, D., de Bari, L., De Filippis, B., Henrion-Caude, A., Vacca, R.A., Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of down syndrome, autism, Fragile X and Rett syndrome. Neurosci. Biobehav. Rev. 46 (2014), 202–217.
133. Valenti, D., de Bari, L., de Rasmo, D., Signorile, A., Henrion-Caude, A., Contestabile, A., Vacca, R.A., The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model. Biochim. Biophys. Acta (BBA) 1862 (2016), 1093–1104.
134. Van Cleve, S.N., Cohen, W.I., Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years. J. Pediatr. Health Care 20 (2006), 47–54.
135. Van Cleve, S.N., Cannon, S., Cohen, W.I., Part II: clinical practice guidelines for adolescents and young adults with Down syndrome: 12 to 21 years. J. Pediatr. Health Care 20 (2006), 198–205.
136. Vauzour, D., Rattray, M., Williams, R.J., Spencer, J.P.E., Potential neuroprotective actions of dietary flavonoids. Ramawat, K.G., Merillion, J.-M., (eds.) Handbook of Natural Products, 2013, Springer, 2617–2640.
137. Visioli, F., Galli, C., Bornet, F., Mattei, A., Patelli, R., Galli, G., Caruso, D., Olive oil phenolics are dose‐dependently absorbed in humans. FEBS Lett. 468 (2000), 159–160.
138. Wang, Y., Xu, H., Fu, Q., Ma, R., Xiang, J., Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats. J. Neurol. Sci. 304 (2011), 29–34.
139. Wang, P., Heber, D., Henning, S.M., Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct. 3 (2012), 635–642.
140. Wang, X., Zhao, Y., Zhang, X., Badie, H., Zhou, Y., Mu, Y., Loo, L.S., Cai, L., Thompson, R.C., Yang, B., Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Nat. Med. 19 (2013), 473–480.
141. Wang, L., Gao, S., Jiang, W., Luo, C., Xu, M., Bohlin, L., Rosendahl, M., Huang, W., Antioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migration. Int. J. Mol. Sci. 15 (2014), 16226–16245.
142. Wang, Y., Li, F., Zhuang, H., Li, L., Chen, X., Zhang, J., Effects of plant polyphenols and α-tocopherol on lipid oxidation, microbiological characteristics, and biogenic amines formation in dry-cured bacons. J. Food Sci. 80 (2015), C547–C555.
143. Xavier, J.M., Rodrigues, C.M., Solá, S., Mitochondria major regulators of neural development. Neuroscientist, 2015 1073858415585472.
144. Yallapu, M.M., Nagesh, P.K.B., Jaggi, M., Chauhan, S.C., Therapeutic applications of curcumin nanoformulations. AAPS J. 17 (2015), 1341–1356.
145. Yang, W.H., Deng, Y.T., Kuo, M.Y.P., Liu, C.M., Chang, H.H., Chang, J.Z.C., Epigallocatechin-3-gallate blocks triethylene glycol dimethacrylate–induced cyclooxygenase-2 expression by suppressing extracellular signal-regulated kinase in human dental pulp and embryonic palatal mesenchymal cells. J. Endod. 39 (2013), 1407–1412.
146. Yong Feng, W., Metabolism of green tea catechins: an overview. Curr. Drug Metab. 7 (2006), 755–809.
147. Yoshino, S., Hara, A., Sakakibara, H., Kawabata, K., Tokumura, A., Ishisaka, A., Kawai, Y., Terao, J., Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Nutrition 27 (2011), 847–852.
148. Yu, D., An, F., He, X., Cao, X., Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138. Int. J. Clin. Exp. Pathol., 8, 2015, 14946.
149. Zhang, J., Nie, S., Wang, S., Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages. J. Agric. Food Chem. 61 (2013), 9200–9209.
150. Zheng, A., Li, H., Cao, K., Xu, J., Zou, X., Li, Y., Chen, C., Liu, J., Feng, Z., Maternal hydroxytyrosol administration improves neurogenesis and cognitive function in prenatally stressed offspring. J. Nutr. Biochem. 26 (2015), 190–199.
151. Zu, Y., Zhang, Y., Wang, W., Zhao, X., Han, X., Wang, K., Ge, Y., Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles. Drug Deliv. 23 (2016), 971–981.
152. Zuo, X., Tian, C., Zhao, N., Ren, W., Meng, Y., Jin, X., Zhang, Y., Ding, S., Ying, C., Ye, X., Tea polyphenols alleviate high fat and high glucose-induced endothelial hyperpermeability by attenuating ROS production via NADPH oxidase pathway. BMC Res. Notes, 7, 2014, 1.